NCT00102388View on ClinicalTrials.gov

Efficacy and Safety of Vildagliptin Compared to Gliclazide in Drug Naive Patients With Type 2 Diabetes

PHASE3CompletedINTERVENTIONAL
Enrollment

1,092

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

March 31, 2008

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

vildagliptin

DRUG

Gliclazide

Trial Locations (2)

Unknown

Novartis Investigative Site, Investigative Centers

Novartis Pharmaceuticals, Basel

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY